RxDoctor Payments Data

Katie Foley

Physician Assistant · Augusta, GANPI 1396427365

Payments from drug & device makers

$2,004in general payments, 2019–2025

Across 73 payments — averaging $27.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$358
  • AbbVie$352
  • Novo Nordisk$321
  • AstraZeneca$235
  • Phathom Pharmaceuticals, Inc.$137
  • Axsome Therapeutics, Inc.$125
  • plus $476 from 11 others

What the payments were for

  • Food & beverage$2,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,004 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$13,382
Medicare patients
65
Services billed
246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin28$19,908
MounjaroTirzepatide11$11,825
UbrelvyUbrogepant12$11,552
EliquisApixaban11$6,372
Diclofenac Sodium12$904
Albuterol Sulfate HfaAlbuterol Sulfate31$737
Fluticasone Propionate32$276
Atorvastatin Calcium54$235
Metoprolol Succinate21$214
Amitriptyline Hcl12$199
Amlodipine Besylate37$194
Hydroxyzine Hcl11$186
Potassium Chloride25$158
Doxycycline Hyclate30$152
Gabapentin27$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$34$19,90828 claims
Lilly USA, LLCMounjaro$358$11,82511 claims
AbbVieUbrelvy$352$11,55212 claims
PfizerEliquis$88$6,37211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →